{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:57:04Z","timestamp":1790686624029,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2021-NR061789"],"award-info":[{"award-number":["RS-2021-NR061789"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016988","name":"Biomedical Research Institute, Jeonbuk National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016988","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"DOI":"10.1186\/s10020-026-01540-2","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:14:26Z","timestamp":1783347266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MIR133B-SEPT9 axis suppresses colorectal cancer progression by inhibiting \u03b2-catenin-mediated EMT signaling and is associated with poor prognosis"],"prefix":"10.1186","volume":"32","author":[{"given":"Ji-Su","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jae","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Sang","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1540_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8029721","volume":"2020","author":"N Abd-Aziz","year":"2020","unstructured":"Abd-Aziz N, Kamaruzman NI, Poh CL. Development of microRNAs as potential therapeutics against cancer. J Oncol. 2020;2020:8029721.","journal-title":"J Oncol"},{"key":"1540_CR2","first-page":"311","volume":"39","author":"P Ak\u00e7akaya","year":"2011","unstructured":"Ak\u00e7akaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, et al. miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol. 2011;39:311\u20138.","journal-title":"Int J Oncol."},{"key":"1540_CR3","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/ijc.30861","volume":"141","author":"KJ Alam","year":"2017","unstructured":"Alam KJ, Mo JS, Han SH, Park WC, Kim HS, Yun KJ, et al. MicroRNA 375 regulates proliferation and migration of colon cancer cells by suppressing the CTGF-EGFR signaling pathway. Int J Cancer. 2017;141:1614\u201329.","journal-title":"Int J Cancer"},{"key":"1540_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1158\/1541-7786.MCR-09-0497","volume":"8","author":"S Amir","year":"2010","unstructured":"Amir S, Golan M, Mabjeesh NJ. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway. Mol Cancer Res. 2010;8:643\u201352.","journal-title":"Mol Cancer Res."},{"key":"1540_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00538","volume":"8","author":"JS Bae","year":"2018","unstructured":"Bae JS, Noh SJ, Kim KM, Park SH, Hussein UK, Park HS, et al. SIRT6 is involved in the progression of ovarian carcinomas via \u03b2-catenin-mediated epithelial to mesenchymal transition. Front Oncol. 2018;8:538.","journal-title":"Front Oncol"},{"key":"1540_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s10585-024-10316-z","volume":"41","author":"J Bai","year":"2024","unstructured":"Bai J, Wang Z, Yang M, Xiang J, Liu Z. Disrupting CENP-N mediated SEPT9 methylation as a strategy to inhibit aerobic glycolysis and liver metastasis in colorectal cancer. Clin Exp Metastasis. 2024;41:971\u201388.","journal-title":"Clin Exp Metastasis."},{"key":"1540_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/path.1484","volume":"201","author":"JF Burrows","year":"2003","unstructured":"Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, et al. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J Pathol. 2003;201:581\u20138.","journal-title":"J Pathol."},{"key":"1540_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12935-014-0070-3","volume":"14","author":"XN Chen","year":"2014","unstructured":"Chen XN, Wang KF, Xu ZQ, Li SJ, Liu Q, Fu DH, et al. MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1. Cancer Cell Int. 2014;14:70.","journal-title":"Cancer Cell Int."},{"key":"1540_CR9","doi-asserted-by":"publisher","first-page":"52983","DOI":"10.18632\/oncotarget.17677","volume":"8","author":"M Chen","year":"2017","unstructured":"Chen M, Li D, Gong N, Wu H, Su C, Xie C, et al. miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs. Oncotarget. 2017;8:52983\u201394.","journal-title":"Oncotarget."},{"key":"1540_CR10","doi-asserted-by":"publisher","first-page":"e71317","DOI":"10.1002\/cam4.71317","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Bai M, Liu M, Zhang Z, Jiang C, Li K, et al. Metabolic reprogramming in lung cancer: hallmarks, mechanisms, and targeted strategies to overcome immune resistance. Cancer Med. 2025;14:e71317.","journal-title":"Cancer Med."},{"key":"1540_CR11","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.3892\/or.2017.5944","volume":"38","author":"Y Cheng","year":"2017","unstructured":"Cheng Y, Jia B, Wang Y, Wan S. MiR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPAR\u03b3 in gastric cancer. Oncol Rep. 2017;38:3220\u20136.","journal-title":"Oncol Rep"},{"key":"1540_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1515\/hsz-2013-0247","volume":"395","author":"D Connolly","year":"2014","unstructured":"Connolly D, Hoang HG, Adler E, Tazearslan C, Simmons N, Bernard VV, et al. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue. Biol Chem. 2014;395:157\u201367.","journal-title":"Biol Chem."},{"key":"1540_CR13","doi-asserted-by":"publisher","first-page":"87147","DOI":"10.18632\/oncotarget.13515","volume":"7","author":"J Dai","year":"2016","unstructured":"Dai J, Wu H, Zhang Y, Gao K, Hu G, Guo Y, et al. Negative feedback between TAp63 and Mir-133b mediates colorectal cancer suppression. Oncotarget. 2016;7:87147\u201360.","journal-title":"Oncotarget."},{"key":"1540_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-164","volume":"12","author":"FT Duan","year":"2013","unstructured":"Duan FT, Qian F, Fang K, Lin KY, Wang WT, Chen YQ. MiR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression. Mol Cancer. 2013;12:164.","journal-title":"Mol Cancer"},{"key":"1540_CR15","first-page":"236","volume":"14","author":"K Felekkis","year":"2010","unstructured":"Felekkis K, Touvana E, Stefanou C, Deltas C. MicroRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia. 2010;14:236\u201340.","journal-title":"Hippokratia"},{"key":"1540_CR16","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1158\/0008-5472.CAN-07-1474","volume":"67","author":"ME Gonzalez","year":"2007","unstructured":"Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res. 2007;67:8554\u201364.","journal-title":"Cancer Res."},{"key":"1540_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cellsig.2008.11.007","volume":"21","author":"ME Gonzalez","year":"2009","unstructured":"Gonzalez ME, Makarova O, Peterson EA, Privette LM, Petty EM. Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cell Signal. 2009;21:477\u201387.","journal-title":"Cell Signal."},{"key":"1540_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/path.3024","volume":"226","author":"PA Hall","year":"2012","unstructured":"Hall PA, Russell SE. Mammalian septins: dynamic heteromers with roles in cellular morphogenesis and compartmentalization. J Pathol. 2012;226:287\u201399.","journal-title":"J Pathol."},{"key":"1540_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4161\/cbt.10.2.12186","volume":"10","author":"G Hu","year":"2010","unstructured":"Hu G, Chen D, Li X, Yang K, Wang H, Wu W. MiR-133b regulates the MET proto-oncogene and inhibits the growth of colorectal cancer cells in vitro and in vivo. Cancer Biol Ther. 2010;10:190\u20137.","journal-title":"Cancer Biol Ther"},{"key":"1540_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153459","volume":"223","author":"C Hu","year":"2021","unstructured":"Hu C, Wu J, Wang L, Liu X, Da B, Liu Y, et al. MiR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8. Pathol Res Pract. 2021;223:153459.","journal-title":"Pathol Res Pract"},{"key":"1540_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/biom14091194","volume":"14","author":"P J\u0119drzejczak","year":"2024","unstructured":"J\u0119drzejczak P, Saramowicz K, Ku\u015b J, Barczuk J, Rozp\u0119dek-Kami\u0144ska W, Siwecka N, et al. SEPT9_i1 and septin dynamics in oncogenesis and cancer treatment. Biomolecules. 2024;14:1194.","journal-title":"Biomolecules."},{"key":"1540_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/genes8010021","volume":"8","author":"W Ji","year":"2017","unstructured":"Ji W, Sun B, Su C. Targeting microRNAs in cancer gene therapy. Genes (Basel). 2017;8:21.","journal-title":"Genes (Basel)"},{"key":"1540_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13148-020-00833-5","volume":"12","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Liu L, Xiang Q, He X, Wang Y, Zhou D, et al. SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt\/\u03b2-catenin signaling pathway via miR92b-3p\/FZD10 in nasopharyngeal carcinoma cells. Clin Epigenet. 2020;12:41.","journal-title":"Clin Epigenet"},{"key":"1540_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.21037\/tlcr.2017.02.07","volume":"6","author":"J Jin","year":"2017","unstructured":"Jin J, Zhan P, Katoh M, Kobayashi SS, Phan K, Qian H, et al. Prognostic significance of \u03b2-catenin expression in patients with non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res. 2017;6:97\u2013108.","journal-title":"Transl Lung Cancer Res"},{"key":"1540_CR25","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138 (Erratum in).","journal-title":"J Clin Invest."},{"key":"1540_CR26","first-page":"3223","volume":"12","author":"S Lamichhane","year":"2022","unstructured":"Lamichhane S, Mo JS, Sharma G, Joung SM, Chae SC. MIR133A regulates cell proliferation, migration, and apoptosis by targeting SOX9 in human colorectal cancer cells. Am J Cancer Res. 2022;12:3223\u201341.","journal-title":"Am J Cancer Res."},{"key":"1540_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199\u2013227.","journal-title":"Annu Rev Pathol."},{"key":"1540_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063178","volume":"25","author":"PD Leiphrakpam","year":"2024","unstructured":"Leiphrakpam PD, Are C. PI3K\/Akt\/mTOR signaling pathway as a target for colorectal cancer treatment. Int J Mol Sci. 2024;25:3178.","journal-title":"Int J Mol Sci"},{"key":"1540_CR29","doi-asserted-by":"publisher","first-page":"50193","DOI":"10.18632\/oncotarget.16745","volume":"8","author":"D Li","year":"2017","unstructured":"Li D, Xia L, Chen M, Lin C, Wu H, Zhang Y, et al. MiR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer. Oncotarget. 2017;8:50193\u2013208.","journal-title":"Oncotarget"},{"key":"1540_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1101\/gad.348226.120","volume":"35","author":"J Li","year":"2021","unstructured":"Li J, Ma X, Chakravarti D, Shalapour S, DePinho RA. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021;35:787\u2013820.","journal-title":"Genes Dev"},{"key":"1540_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03068-z","volume":"16","author":"B Li","year":"2025","unstructured":"Li B, Lin R, Hua Y, Ma B, Chen Y. Single-cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer. Discov Oncol. 2025;16:1256.","journal-title":"Discov Oncol"},{"key":"1540_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-026-04303-5","author":"B Li","year":"2026","unstructured":"Li B, Hong Z, Lin R, Pan J, Xu H, Fang C, et al. TMEM70 drives breast cancer progression via mitochondrial oxidative phosphorylation and microenvironment remodeling. Cancer Cell Int. 2026. https:\/\/doi.org\/10.1186\/s12935-026-04303-5.","journal-title":"Cancer Cell Int"},{"key":"1540_CR33","first-page":"5969","volume":"13","author":"Y Lin","year":"2021","unstructured":"Lin Y, Lin F, Anuchapreeda S, Chaiwongsa R, Duangmano S, Ran B, et al. Effect of miR-133b on progression and cisplatin resistance of triple-negative breast cancer through FGFR1-Wnt-\u03b2-catenin axis. Am J Transl Res. 2021;13:5969\u201384.","journal-title":"Am J Transl Res."},{"key":"1540_CR34","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1038\/s41388-019-1039-4","volume":"39","author":"J Marcus","year":"2020","unstructured":"Marcus J, Bejerano-Sagie M, Patterson N, Bagchi S, Verkhusha VV, Connolly D, et al. Correction: Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions. Oncogene. 2020;39:1830.","journal-title":"Oncogene"},{"key":"1540_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03391-x","volume":"44","author":"MTD Martino","year":"2025","unstructured":"Martino MTD, Tagliaferri P, Tassone P. MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications. J Exp Clin Cancer Res. 2025;44:126.","journal-title":"J Exp Clin Cancer Res"},{"key":"1540_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","volume":"67","author":"IA Mayer","year":"2016","unstructured":"Mayer IA, Arteaga CL. The PI3K\/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016;67:11\u201328.","journal-title":"Annu Rev Med"},{"key":"1540_CR37","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, et al. Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007;1773:1263\u201384.","journal-title":"Biochim Biophys Acta."},{"key":"1540_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/jcm12020408","volume":"12","author":"L Min","year":"2023","unstructured":"Min L, Chen J, Yu M, Liu D. Using circulating tumor DNA as a novel biomarker to screen and diagnose colorectal cancer: a meta-analysis. J Clin Med. 2023;12:408.","journal-title":"J Clin Med."},{"key":"1540_CR39","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1094291","volume":"303","author":"WJ Nelson","year":"2004","unstructured":"Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483\u20137.","journal-title":"Science."},{"key":"1540_CR40","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1038\/ctg.2016.66","volume":"8","author":"J Nian","year":"2017","unstructured":"Nian J, Sun X, Ming S, Yan C, Ma Y, Feng Y, et al. Diagnostic accuracy of methylated SEPT9 for blood-based colorectal cancer detection: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2017;8:e216.","journal-title":"Clin Transl Gastroenterol."},{"key":"1540_CR41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985\u201399.","journal-title":"Cell"},{"key":"1540_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12672-025-02252-5","volume":"16","author":"E Park","year":"2025","unstructured":"Park E, Wang X, Subasi NB, Kmeid M, Higgins PJ, Chen A, et al. SEPT9 and PAI-1 are immunohistochemical biomarkers of the hepatocellular carcinoma immune microenvironment. Discov Oncol. 2025;16:483.","journal-title":"Discov Oncol."},{"key":"1540_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S2468-1253(21)00426-X","volume":"7","author":"SG Patel","year":"2022","unstructured":"Patel SG, Karlitz JJ, Yen T, Lieu CH, Boland CR. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022;7:262\u201374.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"1540_CR44","first-page":"130","volume":"8","author":"G Rafiei","year":"2019","unstructured":"Rafiei G, Shirkoohi R, Saffari M, Salehipour P, Modarressi MH. The impact of long-term exposure to low levels of inorganic arsenic on the hypomethylation of SEPT9 promoter in epithelial-mesenchymal transformed colorectal cancer cell lines. Int J Mol Cell Med. 2019;8:130\u20138.","journal-title":"Int J Mol Cell Med."},{"key":"1540_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203\u201322.","journal-title":"Nat Rev Drug Discov."},{"key":"1540_CR46","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1038\/sj.onc.1208574","volume":"24","author":"M Scott","year":"2005","unstructured":"Scott M, Hyland PL, McGregor G, Hillan KJ, Russell SE, Hall PA. Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours. Oncogene. 2005;24:4688\u2013700.","journal-title":"Oncogene."},{"key":"1540_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/cells8030234","volume":"8","author":"V Skarkova","year":"2019","unstructured":"Skarkova V, Kralova V, Vitovcova B, Rudolf E. Selected aspects of chemoresistance mechanisms in colorectal carcinoma-a focus on epithelial-to-mesenchymal transition, autophagy, and apoptosis. Cells. 2019;8:234.","journal-title":"Cells."},{"key":"1540_CR48","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1158\/1535-7163.MCT-04-0297","volume":"4","author":"SS Sridhar","year":"2005","unstructured":"Sridhar SS, Hedley D, Siu LL. Raf kinase as a target for anticancer therapeutics. Mol Cancer Ther. 2005;4:677\u201385.","journal-title":"Mol Cancer Ther."},{"key":"1540_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1593\/tlo.10109","volume":"3","author":"L Stanbery","year":"2010","unstructured":"Stanbery L, D\u2019Silva NJ, Lee JS, Bradford CR, Carey TE, Prince ME, et al. High SEPT9_v1 expression is associated with poor clinical outcomes in head and neck squamous cell carcinoma. Transl Oncol. 2010;3:239\u201345.","journal-title":"Transl Oncol."},{"key":"1540_CR50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4251\/wjgo.v12.i6.619","volume":"12","author":"J Sun","year":"2020","unstructured":"Sun J, Zheng MY, Li YW, Zhang SW. Structure and function of Septin 9 and its role in human malignant tumors. World J Gastrointest Oncol. 2020;12:619\u201331.","journal-title":"World J Gastrointest Oncol."},{"key":"1540_CR51","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s12253-010-9338-7","volume":"17","author":"K T\u00f3th","year":"2011","unstructured":"T\u00f3th K, Galamb O, Spis\u00e1k S, Wichmann B, Sipos F, Valcz G, et al. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. Pathol Oncol Res. 2011;17:503\u20139.","journal-title":"Pathol Oncol Res."},{"key":"1540_CR52","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/emboj.2012.150","volume":"31","author":"T Valenta","year":"2012","unstructured":"Valenta T, Hausmann G, Basler K. The many faces and functions of \u03b2-catenin. EMBO J. 2012;31:2714\u201336.","journal-title":"EMBO J."},{"key":"1540_CR53","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.3390\/ijms21155353","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H. MicroRNAs and apoptosis in colorectal cancer. Int J Mol Sci. 2020;21:5353.","journal-title":"Int J Mol Sci."},{"key":"1540_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6530934","author":"Z Wang","year":"2022","unstructured":"Wang Z, Wang C, Fu J, Liu R, Zhou X. Cinnamaldehyde downregulation of Sept9 inhibits glioma progression through suppressing Hif-1\u03b1 via the Pi3k\/Akt signaling pathway. Dis Markers. 2022. https:\/\/doi.org\/10.1155\/2022\/6530934.","journal-title":"Dis Markers"},{"key":"1540_CR55","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41586-023-05758-6","volume":"615","author":"AD Weems","year":"2023","unstructured":"Weems AD, Welf ES, Driscoll MK, Zhou FY, Mazloom-Farsibaf H, Chang BJ, et al. Blebs promote cell survival by assembling oncogenic signalling hubs. Nature. 2023;615:517\u201325.","journal-title":"Nature"},{"key":"1540_CR56","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41419-018-0547-4","volume":"9","author":"D Xu","year":"2018","unstructured":"Xu D, Liu A, Wang X, Chen Y, Shen Y, Tan Z, et al. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells. Cell Death Dis. 2018;9:514.","journal-title":"Cell Death Dis."},{"key":"1540_CR57","first-page":"5602","volume":"21","author":"L Yang","year":"2017","unstructured":"Yang L, Hou J, Cui XH, Suo LN, Lv YW. MiR-133b regulates the expression of CTGF in epithelial-mesenchymal transition of ovarian cancer. Eur Rev Med Pharmacol Sci. 2017;21:5602\u20139.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"1540_CR58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.biopha.2018.12.057","volume":"111","author":"W Zeng","year":"2019","unstructured":"Zeng W, Zhu JF, Liu JY, Li YL, Dong X, Huang H, et al. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR. Biomed Pharmacother. 2019;111:476\u201384.","journal-title":"Biomed Pharmacother"},{"key":"1540_CR59","doi-asserted-by":"publisher","first-page":"5625","DOI":"10.7314\/APJCP.2015.16.14.5625","volume":"16","author":"DP Zhang","year":"2015","unstructured":"Zhang DP, Li XW, Lang JH. Prognostic value of \u03b2-catenin expression in breast cancer patients: a meta-analysis. Asian Pac J Cancer Prev. 2015;16:5625\u201333.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1540_CR60","doi-asserted-by":"publisher","first-page":"109768","DOI":"10.1016\/j.biopha.2019.109768","volume":"125","author":"G Zhang","year":"2020","unstructured":"Zhang G, Feng W, Wu J. Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-\u03b2-induced epithelial-mesenchymal transition (EMT). Biomed Pharmacother. 2020;125:109768.","journal-title":"Biomed Pharmacother."},{"issue":"8","key":"1540_CR61","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang N, Ng AS, Cai S, Li Q, Yang L, Kerr D. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol. 2021;22(8):e358.","journal-title":"Lancet Oncol"},{"key":"1540_CR62","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3727\/096504016X14800889609439","volume":"25","author":"Y Zhen","year":"2017","unstructured":"Zhen Y, Liu J, Huang Y, Wang Y, Li W, Wu J. miR-133b inhibits cell growth, migration, and invasion by targeting MMP9 in non-small cell lung cancer. Oncol Res. 2017;25:1109\u201316.","journal-title":"Oncol Res"},{"key":"1540_CR63","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.3892\/mmr.2015.4046","volume":"12","author":"J Zhou","year":"2015","unstructured":"Zhou J, Lv L, Lin C, Hu G, Guo Y, Wu M, et al. Combinational treatment with microRNA-133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR. Mol Med Rep. 2015;12:5407\u201314.","journal-title":"Mol Med Rep"},{"key":"1540_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fmolb.2017.00046","volume":"4","author":"K Zhou","year":"2017","unstructured":"Zhou K, Liu M, Cao Y. New insight into microRNA functions in cancer: oncogene-microRNA-tumor suppressor gene network. Front Mol Biosci. 2017;4:46.","journal-title":"Front Mol Biosci."}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01540-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:07:02Z","timestamp":1790683622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01540-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01540-2","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Institutional Review Boards (IRBs) of Wonkwang University (approval no. WKUIRB-202406-049) and Jeonbuk National University Hospital (IRB No. 2025-09-59), and was conducted in accordance with the principles of the Declaration of Helsinki. All animal experiments were approved by the Institutional Animal Care and Use Committee of Wonkwang University (approval no. WKU24-48).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"164"}}